Journal
CARDIOVASCULAR RESEARCH
Volume 58, Issue 2, Pages 390-398Publisher
OXFORD UNIV PRESS
DOI: 10.1016/S0008-6363(02)00785-X
Keywords
experimental; vasculature; cellular; circulatory physiology
Categories
Ask authors/readers for more resources
The isolation of endothelial progenitor cells (EPCs) derived from bone marrow (BM) was an outstanding event in the recognition of 'de novo vessel formation' in adults occurring as physiological and pathological responses. The finding that EPCs home to sites of neovascularization and differentiate into endothelial cells (ECs) in situ is consistent with 'vasculogenesis', a critical paradigm well described for embryonic neovascularization, but proposed recently in adults in which a reservoir of stem or progenitor cells contributes to vascular organogenesis. EPCs have also been considered, as therapeutic agents to supply the potent origin of neovascularization under pathological conditions. This review provides an update of EPC biology as well as highlighting their potential use for therapeutic regeneration. (C) 2003 European Society of Cardiology. Published by Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available